Factors predicting pituitary adenoma invasiveness in acromegalic patients.
Forty-four adult acromegalic patients carrying growth hormone-producing pituitary macroadenomas were investigated with neuroradiological and endocrinological techniques. Plasma growth hormone and somatomedin-C levels were repeatedly measured before surgical removal of tumors and during the follow-up period. Twenty-five patients presented preoperatively with an invasive adenoma that involved the cavernous sinus (CS). Diagnosis of tumor invasivity was made according to distinct neuroradiological criteria and was confirmed or rejected during surgery Significantly higher basal growth hormone levels were found in patients with CS invasion than in cases without tumor growth in the CS. Evidence is presented that plasma growth hormone level in acromegalics is a more sensitive indicator for predicting tumor invasiveness than somatomedin-C. Growth hormone basal values before surgery and the extent of their decrease after removal of tumor correlate with adenoma growth in the parasellar compartments and should be used as a prognostic factor to aid in planing adjuvant tumor treatment.
Rieger
A
A
Neurosurgical Clinic, Medical Faculty, Martin-Luther-University, Halle/Saale, Fed. Rep. of Germany.
Rainov
N G
NG
Ebel
H
H
Sanchin
L
L
Shibib
K
K
Helfrich
C
C
Hoffmann
O
O
Burkert
W
W
D000172:Acromegaly / Q000097:blood / Q000150:complications*; D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood*; D002426:Cavernous Sinus; D005260:Female; D019382:Human Growth Hormone / Q000097:blood*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D009361:Neoplasm Invasiveness; D010911:Pituitary Neoplasms / Q000097:blood* / Q000150:complications* / Q000473:pathology / Q000601:surgery; D015175:Prolactinoma / Q000097:blood* / Q000150:complications* / Q000473:pathology / Q000601:surgery
D014408:Biomarkers, Tumor; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I